Both in Lab Analytical Instruments
Pacific Biosciences of California vs Seer
Over the past year PACB returned +11.3% and SEER returned −24.0%; their daily moves had a correlation of 0.26.
PACB +11.3% SEER −24.0%Growth of $1, one year, split-adjusted
| Metric | PACB | SEER |
|---|---|---|
| Price | $2.61 | $1.68 |
| Market cap | $809.7M | $93.0M |
| Today | −10.17% | −13.40% |
| 1 month | +3.8% | −23.6% |
| 6 months | +62.8% | −17.2% |
| Year to date | +39.3% | −8.2% |
| 1 year | +29.6% | −24.3% |
| Revenue growth (YoY) | −1.9% | −23.4% |
| Gross margin | 32.4% | 48.5% |
| Net margin | −114.7% | −544.8% |
| P/E (TTM) | — | — |
| Price / sales | 5.1× | 6.5× |
| Net cash | -$407.5M | $152.9M |
| Dividend yield | — | — |
| Volatility (60d) | 114.2% | 44.3% |
| Short % of float | 18.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).